LCN2 and acute kidney injury: Novel urine AKI-specific biomarkers have been identified, including neutrophil gelatinase-associated lipocalin (NGAL), interleukin-18 (IL-18), Kidney Injury Molecule-1 (KIM1) and liver-type fatty acid-binding protein (L-FABP).